Completed
Precision oncology therapies, which target specific abnormalities in a patient’s cancer, are changing the nature of cancer treatment by enabling clinicians to select therapies that are most likely to benefit individual patients. Increasingly, oncologists are formulating cancer treatment plans using results from complex tests that characterize the molecular underpinnings of an individual patient’s cancer. These advances depend on the use of computational methods to analyze large-scale datasets derived from genomic tests and other omics technologies. This workshop examined the challenges and opportunities in the development of computational methods for precision medicine to improve cancer diagnosis and care.
Featured publication
Workshop
·2019
A hallmark of high-quality cancer care is the delivery of the right treatment to the right patient at the right time. Precision oncology therapies, which target specific genetic changes in a patient's cancer, are changing the nature of cancer treatment by allowing clinicians to select therapies that...
View details
Description
An ad hoc committee will plan and host a 1.5-day public workshop to examine the clinical use of high-dimensional (omics) data and computational methods in precision oncology research and clinical care. The workshop will feature invited presentations and panel discussions on topics that may include:
- Challenges and opportunities to use omics data to develop precision medicine approaches and technologies in cancer care.
- Potential standards and best practices for computational software and methodological approaches for the use of big data to inform clinical care of patients with cancer, especially in regard to multi-parameter/multi-treatment testing and interpretation.
- Potential opportunities to improve the translation of omics technologies into oncology practice, such as harmonization of standards for omics-based discovery, development and evaluation; data sharing and reproducibility; oversight and regulation; education, training, and workforce needs; and the use of dissemination and implementation science strategies.
The committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Contributors
Sponsors
American Association for Cancer Research
American Cancer Society
American College of Radiology
American Society of Clinical Oncology
Association of American Cancer Institutes
Association of Community Cancer Centers
Bristol Myers Squibb
Cancer Support Community
Centers for Disease Control and Prevention (CDC)
CEO Roundtable on Cancer
Flatiron Health
Helsinn Therapeutics (U.S.), Inc.
LiveSTRONG Foundation
Merck
National Cancer Institute
National Comprehensive Cancer Network
National Institutes of Health
Novartis Oncology
Oncology Nursing Society
Pfizer Inc.
Staff
Sharyl Nass
Lead
Erin Balogh
Lead
Cyndi Trang
Emily Zevon
Ruth Cooper